Brief: Active Biotech Says Patent For Tasquinimod In Myelofibrosis Granted In Europe
21/05/2025 07:33
May 21 (Reuters) - Active Biotech AB publ ACTI.ST: ACTIVE BIOTECH ANNOUNCES PATENT FOR TASQUINIMOD IN MYELOFIBROSIS GRANTED IN EUROPE PATENT, WITH EUROPEAN PATENT NUMBER, 4185292 PROVIDES PROTECTION AND MARKET EXCLUSIVITY IN STRATEGIC EUROPEAN MARKETS THROUGH 2041 Source text: ID:nMFN1chlbc Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))